Zhang Yang, Shu Zhenyu, Ye Qin, Chen Junfa, Zhong Jianguo, Jiang Hongyang, Wu Cuiyun, Yu Taihen, Pang Peipei, Ma Tianshi, Lin Chunmiao
Department of Radiology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Department of Pharmaceuticals Diagnosis, GE Healthcare, Hangzhou, China.
Front Oncol. 2021 Mar 3;11:633596. doi: 10.3389/fonc.2021.633596. eCollection 2021.
To systematically evaluate and compare the predictive capability for microvascular invasion (MVI) in hepatocellular carcinoma (HCC) patients based on radiomics from multi-parametric MRI (mp-MRI) including six sequences when used individually or combined, and to establish and validate the optimal combined model.
A total of 195 patients confirmed HCC were divided into training (n = 136) and validation (n = 59) datasets. All volumes of interest of tumors were respectively segmented on T-weighted imaging, diffusion-weighted imaging, apparent diffusion coefficient, artery phase, portal venous phase, and delay phase sequences, from which quantitative radiomics features were extracted and analyzed individually or combined. Multivariate logistic regression analyses were undertaken to construct clinical model, respective single-sequence radiomics models, fusion radiomics models based on different sequences and combined model. The accuracy, sensitivity, specificity and area under the receiver operating characteristic curve (AUC) were calculated to evaluate the performance of different models.
Among nine radiomics models, the model from all sequences performed best with AUCs 0.889 and 0.822 in the training and validation datasets, respectively. The combined model incorporating radiomics from all sequences and effective clinical features achieved satisfactory preoperative prediction of MVI with AUCs 0.901 and 0.840, respectively, and could identify the higher risk population of MVI (P < 0.001). The Delong test manifested significant differences with P < 0.001 in the training dataset and P = 0.005 in the validation dataset between the combined model and clinical model.
The combined model can preoperatively and noninvasively predict MVI in HCC patients and may act as a usefully clinical tool to guide subsequent individualized treatment.
基于多参数磁共振成像(mp-MRI)的六个序列单独或联合使用时的影像组学,系统评估和比较肝细胞癌(HCC)患者微血管侵犯(MVI)的预测能力,并建立和验证最佳联合模型。
总共195例确诊为HCC的患者被分为训练集(n = 136)和验证集(n = 59)。在T加权成像、扩散加权成像、表观扩散系数、动脉期、门静脉期和延迟期序列上分别分割所有肿瘤感兴趣区,从中单独或联合提取并分析定量影像组学特征。进行多变量逻辑回归分析以构建临床模型、各自的单序列影像组学模型、基于不同序列的融合影像组学模型和联合模型。计算准确性、敏感性、特异性和受试者操作特征曲线下面积(AUC)以评估不同模型的性能。
在九个影像组学模型中,所有序列的模型表现最佳,训练集和验证集的AUC分别为0.889和0.822。结合所有序列的影像组学和有效临床特征的联合模型对MVI的术前预测效果良好,AUC分别为0.901和0.840,并且可以识别MVI的高风险人群(P < 0.001)。Delong检验表明,联合模型与临床模型在训练集中差异显著(P < 0.001),在验证集中差异为P = 0.005。
联合模型可以在术前对HCC患者的MVI进行无创预测,并可能作为一种有用的临床工具来指导后续的个体化治疗。